Records containing: Systemic Lupus Erthematosus (SLE)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-02An Exploratory Clinical Study Evaluate the Safety and Efficacy of Universal Universal Allogeneic CAR-T Cells Targeting CD19 and BCMA in the Treatment of B Cell-Related Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2026-03-25A Phase 1, Open Label Dose Escalating Study of HB2198, a Tetravalent Bispecific Anti-CD19/CD20 Antibody With Dual Fc Domains, in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-02-03A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2026-01-22A Multicenter Phase I Clinical Study of CD19-Targeted CAR-NK Cell Therapy for Moderate to Severe Active Systemic Lupus Erythematosus in China
-
CLINICAL_TRIALS study record update · 2025-12-12The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-10Scavenging IsoLGs in Autoimmune Disease: a Proof-of-concept Clinical Study
-
CLINICAL_TRIALS study record update · 2025-09-02CARe RAiSE Study - Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy